7 atomic-physics "Henry M" Fellowship positions at Center for Devices and Radiological Health (CDRH)

Research Fellowship in Medical Hyperspectral Imaging at the US Food and Drug Administration (FDA)

*Applications will be reviewed on a rolling-basis. A research opportunity is available in the Center for Devices and Radiological Health (CDRH), Food and Drug Administration (FDA) located in Silver

FDA Fellowship in Magnetic Resonance Imaging (MRI) Safety

for Devices and Radiological Health (CDRH), Food and Drug Administration (FDA) located at the White Oak Federal Research Center in Silver Spring, Maryland. The fellow is expected to be located on-site but some

FDA Using Real-World Data to Identify Total Knee Arthroplasties (TKA) with Higher Revision Rates Fellowship

Administration (FDA) located in Silver Spring, Maryland. Research Project: The FDA has authorized hundreds of knee replacement devices (TKA) available for the American doctors and patients; however, some of them

FDA-OSEL Research Fellowship on Deep Learning Assisted Medical Image Reconstruction

required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there

FDA Postdoctoral Fellowship: Analytical Chemist for Medical Device Research

Health (CDRH), Food and Drug Administration (FDA) located in Silver Spring, Maryland. The research will involve performing studies related to analysis of extractable and leachable chemicals from materials

FDA Postdoctoral Fellowship in Computational Metagenomics

. Food and Drug Administration (FDA) located in Silver Spring, Maryland. The position will engage with scientific staff in a funded project to quantify the effect of reference sequence database structure

FDA Biomedical/Electrical/Mechanical Engineer Research Fellowship

Health (CDRH), Food and Drug Administration (FDA) located in Silver Spring, Maryland. The candidate will join a research team studying regulatory science questions to advance new patient monitoring and